Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
31.24
Dollar change
-0.32
Percentage change
-1.01
%
IndexRUT P/E72.26 EPS (ttm)0.43 Insider Own1.06% Shs Outstand48.84M Perf Week2.43%
Market Cap1.53B Forward P/E33.84 EPS next Y0.92 Insider Trans384.30% Shs Float48.30M Perf Month7.24%
Income21.35M PEG2.41 EPS next Q0.03 Inst Own105.68% Short Float13.35% Perf Quarter-2.28%
Sales322.42M P/S4.73 EPS this Y-43.02% Inst Trans1.94% Short Ratio8.18 Perf Half Y-30.42%
Book/sh7.90 P/B3.95 EPS next Y60.42% ROA4.72% Short Interest6.45M Perf Year-43.60%
Cash/sh4.52 P/C6.91 EPS next 5Y30.00% ROE5.95% 52W Range26.66 - 73.13 Perf YTD0.10%
Dividend Est.- P/FCF- EPS past 5Y31.51% ROI5.11% 52W High-57.28% Beta0.84
Dividend TTM- Quick Ratio5.08 Sales past 5Y21.55% Gross Margin78.36% 52W Low17.20% ATR (14)1.63
Dividend Ex-Date- Current Ratio5.62 EPS Y/Y TTM-45.63% Oper. Margin8.71% RSI (14)52.48 Volatility6.32% 4.99%
Employees1115 Debt/Eq0.09 Sales Y/Y TTM13.37% Profit Margin6.62% Recom2.33 Target Price42.25
Option/ShortYes / Yes LT Debt/Eq0.08 EPS Q/Q32.91% Payout0.00% Rel Volume0.72 Prev Close31.56
Sales Surprise0.43% EPS Surprise-27.29% Sales Q/Q19.09% EarningsFeb 26 AMC Avg Volume788.04K Price31.24
SMA203.35% SMA501.96% SMA200-24.95% Trades Volume565,239 Change-1.01%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Downgrade Needham Buy → Hold
Dec-04-23Initiated Morgan Stanley Equal-Weight $35
Sep-15-23Downgrade The Benchmark Company Buy → Hold
Aug-03-23Downgrade Canaccord Genuity Buy → Hold $77 → $48
Jun-07-23Downgrade William Blair Outperform → Mkt Perform
Apr-17-23Initiated Piper Sandler Neutral $65
Feb-06-23Downgrade BTIG Research Buy → Neutral
Dec-28-22Reiterated BTIG Research Buy $80 → $67
Dec-08-22Initiated Stifel Hold $60
Nov-07-22Upgrade Sidoti Neutral → Buy
Feb-28-24 10:58AM
Feb-27-24 02:00PM
Feb-26-24 05:30PM
04:39PM
04:34PM
04:01PM Loading…
04:01PM
Feb-19-24 07:00AM
Jan-27-24 01:03PM
Jan-23-24 07:00AM
Jan-12-24 06:49PM
Jan-08-24 07:00AM
Dec-17-23 12:35PM
Dec-05-23 03:16AM
Dec-04-23 04:05PM
Nov-15-23 07:00AM
05:50PM Loading…
Nov-02-23 05:50PM
09:23AM
Nov-01-23 06:30PM
05:56PM
04:17PM
04:01PM
Oct-31-23 04:40PM
Oct-18-23 04:05PM
Oct-17-23 07:00AM
Oct-13-23 06:30PM
Oct-10-23 10:51AM
Sep-19-23 11:51AM
Sep-15-23 09:32AM
Sep-14-23 12:53PM
07:00AM
11:38AM Loading…
Sep-08-23 11:38AM
Sep-07-23 05:00PM
Aug-18-23 10:40AM
Aug-17-23 06:48PM
Aug-09-23 07:00AM
Aug-07-23 07:00AM
05:00AM
Aug-03-23 07:18PM
Aug-02-23 05:25PM
04:21PM
04:01PM
Jul-19-23 07:00AM
Jun-21-23 08:00PM
Jun-13-23 08:00AM
May-26-23 06:00AM
May-17-23 10:10AM
May-09-23 01:48PM
May-04-23 07:00AM
May-03-23 05:35PM
04:29PM
04:01PM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
10:02AM
Apr-23-23 08:25AM
Apr-19-23 07:00AM
Apr-07-23 11:44AM
Apr-04-23 06:00PM
Mar-29-23 06:00PM
07:00AM
Mar-23-23 06:00PM
Mar-15-23 05:50PM
Mar-13-23 08:48AM
Mar-09-23 05:25AM
Feb-23-23 05:12AM
Feb-21-23 05:15PM
04:01PM
Feb-13-23 05:50PM
Feb-07-23 07:00AM
Feb-03-23 05:50PM
01:58PM
09:00AM
Jan-31-23 09:25AM
Jan-25-23 06:00PM
Jan-24-23 03:26PM
Jan-17-23 06:00PM
Jan-11-23 07:00AM
Jan-10-23 06:41AM
Jan-09-23 07:00AM
Jan-06-23 09:13PM
01:52PM
Dec-30-22 07:17AM
Dec-20-22 08:56AM
Dec-19-22 08:15AM
Dec-13-22 11:01AM
Nov-28-22 01:18PM
Nov-17-22 07:00AM
Nov-13-22 09:28AM
Nov-11-22 08:38AM
Nov-02-22 05:25PM
04:01PM
Oct-29-22 10:49AM
Oct-24-22 12:45PM
Oct-19-22 07:00AM
Oct-12-22 07:00AM
Oct-07-22 12:45PM
Oct-02-22 10:45AM
Sep-19-22 01:39PM
Sep-17-22 08:48AM
Sep-14-22 07:00AM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROADWOOD PARTNERS, L.P.10% OwnerJan 08Buy27.114,042109,57010,768,430Jan 10 05:44 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 05Buy28.48156,7344,463,23110,764,388Jan 05 07:07 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 04Buy28.9163,2461,828,18310,607,654Jan 05 07:07 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 03Buy28.936,573190,14410,544,408Jan 05 07:07 PM
Zhou Lilian YanshengDirectorDec 06Buy30.7485026,1292,327Dec 06 04:11 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 30Buy31.42177,7075,583,67810,537,835Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 29Buy31.39160,3005,031,35810,360,128Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 28Buy31.8596,9843,088,79410,199,828Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 13Buy33.0450716,74910,102,844Nov 14 07:13 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 10Buy32.7334,3201,123,38310,102,337Nov 14 07:13 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 09Buy33.09140,0004,632,58110,068,017Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 08Buy33.71139,4094,699,0739,928,017Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 07Buy34.039,731331,1279,788,608Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 06Buy34.16164,6075,623,5189,778,877Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 03Buy36.0652018,7539,614,270Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 02Buy35.79144,0275,155,2439,613,750Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.10% OwnerOct 06Buy37.6275,2992,832,4179,469,723Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.10% OwnerOct 05Buy37.9297,4743,696,3999,394,424Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.10% OwnerOct 04Buy37.9332,5231,233,6499,296,950Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.10% OwnerSep 21Buy39.62154,8146,133,4679,264,427Sep 21 08:31 PM
Lin Elizabeth YeuDirectorSep 21Buy40.002,500100,0002,855Sep 22 07:18 PM
BROADWOOD PARTNERS, L.P.10% OwnerSep 20Buy40.67132,0795,372,2749,109,613Sep 21 08:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerSep 19Buy40.894,490183,6138,977,534Sep 21 08:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerSep 07Buy41.2660,8742,511,7228,973,044Sep 07 07:00 PM
BROADWOOD PARTNERS, L.P.10% OwnerSep 06Buy41.43108,9444,513,7358,912,170Sep 07 07:00 PM
BROADWOOD PARTNERS, L.P.10% OwnerSep 05Buy41.8720,144843,4558,803,226Sep 07 07:00 PM
Williams Patrick F.Chief Financial OfficerAug 10Option Exercise0.005,122045,400Aug 11 06:01 PM
WEISNER AIMEE SDirectorAug 07Buy48.722,00097,4405,417Aug 07 04:16 PM
FARRELL STEPHEN CDirectorJun 15Option Exercise0.001,70908,276Jun 16 08:41 PM
Kliman Gilbert HDirectorJun 15Option Exercise0.003,41709,656Jun 16 08:39 PM
WEISNER AIMEE SDirectorJun 15Option Exercise0.003,41703,417Jun 16 08:37 PM
Yu K PeonyDirectorJun 15Option Exercise0.001,70902,786Jun 16 08:35 PM
Williams Patrick F.Chief Financial OfficerJun 06Option Exercise0.005,121047,387Jun 07 04:53 PM
Michna MagdaChief Clinical, Regulatory,May 08Option Exercise0.0014,047014,047May 09 05:26 PM
Foust WarrenChief Operating OfficerMay 08Option Exercise0.0020,331020,331May 09 05:24 PM
Holliday KeithChief Technology OfficerMar 17Sale61.9782351,00127,633Mar 17 06:04 PM
Barnes Scott DChief Medical OfficerMar 10Option Exercise0.0010,555040,810Mar 10 09:39 PM
Francese James ESr. VP, Comm. Ops., NA, APACMar 10Option Exercise0.008,388042,374Mar 10 09:38 PM
Gesten Samuel JChief Legal OfficerMar 10Option Exercise0.009,531043,219Mar 10 09:37 PM
Holliday KeithChief Technology OfficerMar 10Option Exercise0.0010,192028,456Mar 10 09:36 PM
Studholme RobertSenior VP, OperationsMar 10Option Exercise0.008,859031,980Mar 10 09:34 PM
Williams Patrick F.Chief Financial OfficerMar 10Option Exercise0.0012,184045,676Mar 10 09:35 PM
Williams Patrick F.Chief Financial OfficerMar 07Option Exercise58.131,71199,46035,492Mar 08 08:18 PM
Studholme RobertSenior VP, OperationsMar 07Option Exercise58.131,70999,34423,121Mar 08 08:18 PM
Barnes Scott DChief Medical OfficerMar 07Option Exercise58.131,60393,18232,143Mar 08 08:14 PM
Holliday KeithChief Technology OfficerMar 07Option Exercise58.131,43183,18419,979Mar 08 08:17 PM
Gesten Samuel JChief Legal OfficerMar 07Option Exercise58.131,33877,77835,306Mar 08 08:16 PM
Francese James ESr. VP, Comm. Ops., NA, APACMar 07Option Exercise58.131,08362,95535,319Mar 08 08:15 PM
Last Close
Feb 29 04:00PM ET
4.88
Dollar change
-0.12
Percentage change
-2.40
%
LNSR LENSAR Inc daily Stock Chart
Index- P/E- EPS (ttm)-1.23 Insider Own18.06% Shs Outstand11.09M Perf Week11.67%
Market Cap54.90M Forward P/E- EPS next Y-0.74 Insider Trans0.14% Shs Float9.22M Perf Month41.04%
Income-12.95M PEG- EPS next Q-0.22 Inst Own42.50% Short Float0.49% Perf Quarter96.77%
Sales40.29M P/S1.36 EPS this Y17.44% Inst Trans-0.50% Short Ratio1.41 Perf Half Y39.43%
Book/sh3.24 P/B1.51 EPS next Y54.00% ROA-20.61% Short Interest0.04M Perf Year57.93%
Cash/sh2.22 P/C2.20 EPS next 5Y- ROE-27.93% 52W Range1.80 - 5.23 Perf YTD39.03%
Dividend Est.- P/FCF- EPS past 5Y-10.39% ROI-24.89% 52W High-6.69% Beta0.52
Dividend TTM- Quick Ratio2.83 Sales past 5Y11.21% Gross Margin52.96% 52W Low171.11% ATR (14)0.45
Dividend Ex-Date- Current Ratio4.42 EPS Y/Y TTM43.13% Oper. Margin-29.49% RSI (14)61.10 Volatility8.74% 11.28%
Employees110 Debt/Eq0.05 Sales Y/Y TTM10.85% Profit Margin-32.13% Recom1.00 Target Price8.00
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q155.03% Payout- Rel Volume0.94 Prev Close5.00
Sales Surprise-3.97% EPS Surprise31.97% Sales Q/Q26.42% EarningsMar 04 BMO Avg Volume31.71K Price4.88
SMA208.47% SMA5024.35% SMA20049.20% Trades Volume29,955 Change-2.40%
Date Action Analyst Rating Change Price Target Change
Feb-24-21Initiated SVB Leerink Outperform $20
Feb-26-24 08:00AM
Nov-12-23 09:38AM
Nov-09-23 07:00AM
Nov-02-23 08:03AM
Aug-09-23 07:00AM
07:00AM Loading…
Jul-24-23 07:00AM
May-15-23 07:00AM
May-10-23 08:00AM
Mar-20-23 03:05AM
Mar-16-23 07:00AM
Mar-09-23 08:00AM
Feb-14-23 07:00AM
Nov-22-22 08:00AM
Nov-09-22 07:00AM
Nov-02-22 08:00AM
07:00AM Loading…
Sep-08-22 07:00AM
Aug-16-22 07:00AM
Aug-08-22 07:00AM
Aug-01-22 08:00AM
Jun-13-22 07:00AM
Jun-09-22 07:30AM
May-09-22 07:00AM
May-02-22 08:00AM
Apr-21-22 09:08AM
Mar-03-22 07:00AM
Mar-01-22 07:00AM
Feb-28-22 04:01PM
Feb-23-22 02:01AM
Feb-10-22 08:00AM
Jan-04-22 08:00AM
07:53AM Loading…
Dec-31-21 07:53AM
Nov-16-21 08:00AM
Nov-12-21 07:00AM
Nov-08-21 07:00AM
Nov-01-21 08:00AM
Oct-02-21 10:32AM
Sep-02-21 08:00AM
Aug-16-21 08:00AM
Aug-05-21 07:00AM
Jul-29-21 08:00AM
Jul-15-21 08:00AM
May-24-21 08:00AM
May-05-21 07:00AM
06:45AM
Apr-28-21 08:00AM
Mar-10-21 07:00AM
Mar-03-21 04:05PM
Feb-16-21 01:28PM
Feb-08-21 08:00AM
Feb-01-21 07:00AM
Jan-03-21 03:58AM
Nov-23-20 08:00AM
Nov-11-20 04:01PM
Nov-09-20 04:01PM
Nov-02-20 08:00AM
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winer Gary MDirectorNov 22Buy2.1030063053,345Nov 27 07:30 PM
Winer Gary MDirectorNov 16Buy2.121,0002,12553,045Nov 17 06:18 PM
Winer Gary MDirectorNov 15Buy2.155001,07552,045Nov 17 06:18 PM
Winer Gary MDirectorNov 10Buy2.131,0002,13551,545Nov 14 07:31 PM
Winer Gary MDirectorAug 11Buy3.607052,53850,545Aug 14 07:01 PM
Winer Gary MDirectorAug 10Buy3.661,0003,66049,840Aug 14 07:01 PM
WEISNER AIMEE SDirectorMay 22Buy2.7516,64745,77954,285May 23 04:45 PM
WEISNER AIMEE SDirectorMay 19Buy2.5922,15357,37637,638May 19 06:54 PM
WEISNER AIMEE SDirectorMay 18Buy2.617,70020,09715,485May 19 06:54 PM
WEISNER AIMEE SDirectorMay 17Buy2.293,5008,0157,785May 19 06:54 PM